MMJ BioPharma’s noble pursuit of scientific advancement has been met with a series of inexplicable roadblocks and bureaucratic hurdles erected by the DEA. In 2018, the company dutifully applied for the necessary licenses to cultivate marijuana for research and development purposes, eagerly anticipating the opportunity to commence clinical trials that could yield life-changing treatments. Yet, despite meticulously following the DEA’s convoluted application process, MMJ BioPharma found itself trapped in a seemingly endless cycle of delays, obfuscation, and stonewalling.
4,516 people logged what they drank for three weeks. On the days they had a…
Matthew McConaughey has apparently discovered the outer limit of how many consecutive plays of Janet…
Every CBD-for-athletes pitch of the last decade has sold the same story: sore muscles, faster…
Here's a fact that gets lost in the cigarette-versus-weed conversation: nicotine is a genuinely psychoactive…
Headlines around the world tied a captain’s positive marijuana test to a terrifying midair plunge.…
We’ve all had nightmares at some point. The agitation, the fear, the scenarios our own…